,mean_rank,weight
cervix,10.0,3.0
adrenal gland neuroblastoma,26.0,5.0
small cell lung carcinoma,28.5,88.0
lung carcinoma,35.0,1.0
pancreatic somatostatinoma,35.0,3.0
supraclavicular lymph node,43.0,3.0
adrenal gland,45.0,3.0
neuroblastoma,60.5,52.0
endometrioid stromal sarcoma,64.0,3.0
vertebra,64.5,2.0
lung carcinoid tumor,68.5,6.0
medulloblastoma,74.0,8.0
thyroid gland squamous cell carcinoma,83.0,3.0
right pararenal lymph node,83.0,2.0
gastric small cell neuroendocrine carcinoma,84.0,4.0
prostate carcinoma,88.0,11.0
inguinal lymph node,99.0,3.0
embryonal carcinoma,101.0,1.0
cervical small cell carcinoma,105.0,1.0
right thigh skin,106.0,2.0
right anterior leg,108.0,3.0
hereditary thyroid gland medullary carcinoma,109.0,1.0
multiple endocrine neoplasia type 2,109.0,1.0
brain,113.0,16.0
testicular embryonal carcinoma,121.0,1.0
invasive lobular breast carcinoma,128.0,1.0
neurofibromatosis type 1,135.0,1.0
peritoneal ascites,136.5,2.0
salivary gland squamous cell carcinoma,137.0,3.0
ovarian granulosa cell tumor,139.5,2.0
subserosa of fallopian tube,141.0,1.0
skin nodule,142.0,1.0
high grade ovarian serous adenocarcinoma,149.0,40.0
ewing sarcoma,154.0,31.0
large cell lung carcinoma,155.5,32.0
bronchogenic carcinoma,160.0,2.0
pharyngeal squamous cell carcinoma,162.0,3.0
embryonal rhabdomyosarcoma,165.0,6.0
primitive neuroectodermal tumor,175.5,2.0
bone marrow,176.0,65.0
alveolar rhabdomyosarcoma,176.0,9.0
mediastinal lymph node,178.0,1.0
hypopharyngeal squamous cell carcinoma,179.0,5.0
oligodendroglioma,180.0,5.0
ovarian carcinoma,193.0,6.0
squamous cell lung carcinoma,193.5,48.0
papillary renal cell carcinoma,195.0,5.0
osteosarcoma,198.0,23.0
rhabdomyosarcoma,204.0,4.0
ovarian leiomyosarcoma,204.0,3.0
ovarian adenocarcinoma,206.0,5.0
lung giant cell carcinoma,209.0,4.0
gastric adenosquamous carcinoma,220.5,2.0
adenosquamous lung carcinoma,223.0,9.0
thyroid gland follicular carcinoma,224.0,10.0
liposarcoma,226.0,1.0
"squamous cell breast carcinoma, acantholytic variant",229.0,3.0
lung mucoepidermoid carcinoma,230.0,3.0
minimally invasive lung adenocarcinoma,234.0,16.0
subcutaneous,237.0,7.0
abdominal wall,237.0,2.0
ovarian endometrioid adenocarcinoma,240.0,11.0
erythroleukemia,240.0,3.0
abdomen,240.0,2.0
squamous papilloma,241.0,1.0
ovarian serous cystadenocarcinoma,247.5,4.0
gastric choriocarcinoma,256.0,1.0
endometrial carcinoma,262.0,8.0
pleural epithelioid mesothelioma,266.5,18.0
not specified,270.0,3.0
supra-orbital region,271.0,1.0
endometrial adenosquamous carcinoma,272.0,6.0
ovarian mixed germ cell tumor,274.0,1.0
tonsillar squamous cell carcinoma,277.0,1.0
duodenal adenocarcinoma,285.0,1.0
gestational choriocarcinoma,286.0,2.0
plasma cell myeloma,287.0,30.0
cutaneous melanoma,287.5,26.0
natural killer cell lymphoblastic leukemia/lymphoma,291.0,1.0
groin lymph node,303.0,5.0
cervical squamous cell carcinoma,305.0,1.0
uterine carcinosarcoma,310.0,2.0
spleen,312.0,3.0
pleural sarcomatoid mesothelioma,312.0,8.0
esophageal squamous cell carcinoma,312.0,59.0
rhabdoid tumor of the kidney,315.0,3.0
pleural effusion,316.0,224.0
melanoma,316.5,94.0
ductal breast carcinoma,321.5,32.0
lymph node,324.0,105.0
glioblastoma,324.5,84.0
n/a,325.5,34.0
askin tumor,327.5,2.0
ascites,331.0,103.0
breast carcinoma,333.0,27.0
bladder carcinoma,335.0,51.0
chondrosarcoma,337.0,10.0
ovarian serous adenocarcinoma,339.0,7.0
pelvic wall,339.0,3.0
thigh skin,340.0,1.0
brachialis muscle,343.0,3.0
lymphoma,345.0,1.0
axillary lymph node,348.0,6.0
clear cell renal cell carcinoma,352.0,18.0
cerebrospinal fluid,352.0,3.0
lung adenocarcinoma,356.0,145.0
"invasive ductal carcinoma, not otherwise specified",357.0,30.0
marek disease,360.0,1.0
acute myeloid leukemia,361.0,1.0
gastric fundus carcinoma,361.0,1.0
astrocytoma,362.0,19.0
thyroid gland undifferentiated (anaplastic) carcinoma,366.0,13.0
pleural biphasic mesothelioma,369.0,7.0
gastric adenocarcinoma,373.0,26.0
skin,374.0,3.0
intraperitoneal,376.0,1.0
mucinous gastric adenocarcinoma,376.0,3.0
hodgkin lymphoma,378.0,11.0
hepatocellular carcinoma,379.0,51.0
ovarian mucinous adenocarcinoma,382.0,4.0
uterine corpus sarcoma,383.0,3.0
brca1 syndrome,385.0,1.0
peritoneum,386.0,1.0
colon adenocarcinoma,386.0,61.0
pancreatic carcinoma,389.0,12.0
left leg muscle,392.0,3.0
childhood acute myeloid leukemia with maturation,392.0,1.0
hepatoblastoma,393.0,4.0
celiac axis lymph node,394.0,2.0
omentum,395.0,7.0
left supraclavicular lymph node,395.5,4.0
poorly differentiated thyroid gland carcinoma,396.0,3.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",397.5,2.0
thoracic lymph duct,399.0,1.0
thyroid gland sarcoma,401.0,1.0
laryngeal squamous cell carcinoma,403.0,12.0
pleural malignant mesothelioma,406.0,5.0
ovarian clear cell adenocarcinoma,407.0,13.0
gastric carcinoma,408.0,12.0
breast adenocarcinoma,410.0,23.0
renal cell carcinoma,410.0,37.0
intrahepatic cholangiocarcinoma,417.5,6.0
pelvis; innominate bone,418.0,2.0
brca2 syndrome,418.0,1.0
buttock,419.0,2.0
ovarian cystadenocarcinoma,430.5,6.0
tongue squamous cell carcinoma,432.0,34.0
right axillary lymph node,432.0,1.0
childhood acute myeloid leukemia,433.5,2.0
adult acute monocytic leukemia,438.0,5.0
gingival squamous cell carcinoma,439.0,2.0
amelanotic melanoma,439.0,16.0
biphasic synovial sarcoma,440.0,1.0
pericardial effusion,447.0,8.0
bladder squamous cell carcinoma,447.0,3.0
endometrial adenocarcinoma,447.5,34.0
hairy cell leukemia,448.0,3.0
primary effusion lymphoma,449.0,3.0
"chronic myelogenous leukemia, bcr-abl1 positive",449.5,16.0
anaplastic large cell lymphoma,457.5,8.0
myeloid leukemia associated with down syndrome,460.0,1.0
malignant ovarian brenner tumor,462.0,1.0
colon carcinoma,465.0,19.0
pancreatic adenosquamous carcinoma,465.0,5.0
cecum adenocarcinoma,466.0,18.0
gliosarcoma,467.0,6.0
myelodysplastic syndrome,467.0,1.0
lung,470.0,7.0
small intestine,470.0,1.0
non-small cell lung carcinoma,473.0,24.0
gastric tubular adenocarcinoma,474.0,11.0
liver,474.5,32.0
cutaneous t-cell non-hodgkin lymphoma,475.5,2.0
gallbladder carcinoma,479.0,2.0
mycosis fungoides and sezary syndrome,481.0,2.0
rectal adenocarcinoma,491.0,11.0
mantle cell lymphoma,491.0,6.0
childhood t acute lymphoblastic leukemia,492.0,19.0
childhood t lymphoblastic lymphoma,495.0,2.0
peripheral blood,499.0,107.0
pancreatic adenocarcinoma,504.0,39.0
ovarian mucinous cystadenocarcinoma,504.0,2.0
epithelioid cell type gastrointestinal stromal tumor,507.0,3.0
mediastinal (thymic) large b-cell lymphoma,507.0,1.0
chronic lymphocytic leukemia,509.0,2.0
ampulla of vater adenocarcinoma,514.5,2.0
mandible,515.0,1.0
familial adenomatous polyposis,515.0,1.0
pancreatic ductal adenocarcinoma,516.0,39.0
undifferentiated pleomorphic sarcoma,516.0,4.0
b-cell prolymphocytic leukemia,524.0,2.0
rectosigmoid adenocarcinoma,527.0,3.0
uterine corpus leiomyosarcoma,531.0,3.0
undifferentiated gallbladder carcinoma,533.0,1.0
diffuse large b-cell lymphoma activated b-cell type,535.0,1.0
pyriform fossa squamous cell carcinoma,537.0,1.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",544.0,2.0
skin squamous cell carcinoma,550.0,1.0
human papillomavirus-related cervical squamous cell carcinoma,555.5,8.0
childhood b acute lymphoblastic leukemia,556.0,9.0
adult t acute lymphoblastic leukemia,558.0,5.0
vulvar carcinoma,565.0,1.0
human papillomavirus-related endocervical adenocarcinoma,567.0,4.0
recurrent bladder carcinoma,567.0,3.0
b acute lymphoblastic leukemia,569.0,5.0
barrett adenocarcinoma,574.0,3.0
fibrosarcoma,578.0,5.0
epstein-barr virus-related burkitt lymphoma,578.5,10.0
adrenal cortex carcinoma,580.0,1.0
diffuse large b-cell lymphoma germinal center b-cell type,583.0,8.0
vulvar leiomyosarcoma,586.0,3.0
cervical lymph node,598.0,5.0
hilar cholangiocarcinoma,599.0,1.0
obturator lymph node,602.0,3.0
oral cavity squamous cell carcinoma,602.5,6.0
signet ring cell gastric adenocarcinoma,605.0,9.0
subcutaneous; right buttock,608.0,3.0
down syndrome,611.0,2.0
papillary lung adenocarcinoma,613.0,3.0
epithelioid sarcoma,621.0,1.0
paragastric lymph node,622.0,2.0
esophageal adenocarcinoma,632.0,9.0
bone,633.0,1.0
b-cell non-hodgkin lymphoma,641.0,7.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,643.0,3.0
peritoneal effusion,644.0,6.0
vaginal melanoma,656.0,1.0
cervical carcinoma,662.5,2.0
floor of mouth squamous cell carcinoma,676.0,1.0
cystic fibrosis,680.5,2.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),684.5,4.0
cholangiocarcinoma,701.0,2.0
benign prostatic hyperplasia,701.0,1.0
burkitt lymphoma,703.5,8.0
childhood acute monocytic leukemia,711.5,2.0
hereditary spherocytosis,712.0,1.0
splenic lymphoma with circulating villous lymphocytes,720.0,1.0
buccal mucosa squamous cell carcinoma,727.0,2.0
left cervical lymph node,731.0,1.0
thyroid gland papillary carcinoma,731.0,1.0
vulvar squamous cell carcinoma,732.0,3.0
adult b acute lymphoblastic leukemia,750.0,3.0
diffuse large b-cell lymphoma,763.5,20.0
parotid gland mucoepidermoid carcinoma,765.0,1.0
adult acute myeloid leukemia,814.5,22.0
anaplastic astrocytoma,829.0,5.0
vulvar melanoma,839.0,1.0
head and neck squamous cell carcinoma,841.0,9.0
"chronic eosinophilic leukemia, not otherwise specified",862.0,1.0
follicular lymphoma,864.0,2.0
lymphoblastic lymphoma,876.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,884.0,1.0
ovary,887.0,1.0
oral dysplasia,895.0,1.0
meninges,947.0,1.0
acute myelomonocytic leukemia,947.0,1.0
squamous cell carcinoma,957.0,1.0
